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Abstract: Intracellular Ca2+ signalling is a major signal transductional pathway in non-excitable cells,
responsible for the regulation of a variety of physiological functions. In the secretory epithelial cells of
the exocrine pancreas, such as acinar and ductal cells, intracellular Ca2+ elevation regulates digestive
enzyme secretion in acini or fluid and ion secretion in ductal cells. Although Ca2+ is a uniquely
versatile orchestrator of epithelial physiology, unregulated global elevation of the intracellular Ca2+
concentration is an early trigger for the development of acute pancreatitis (AP). Regardless of the
aetiology, different forms of AP all exhibit sustained intracellular Ca2+ elevation as a common
hallmark. The release of endoplasmic reticulum (ER) Ca2+ stores by toxins (such as bile acids or fatty
acid ethyl esters (FAEEs)) or increased intrapancreatic pressure activates the influx of extracellular
Ca2+ via the Orai1 Ca2+ channel, a process known as store-operated Ca2+ entry (SOCE). Intracellular
Ca2+ overload can lead to premature activation of trypsinogen in pancreatic acinar cells and impaired
fluid and HCO3- secretion in ductal cells. Increased and unbalanced reactive oxygen species (ROS)
production caused by sustained Ca2+ elevation further contributes to cell dysfunction, leading to
mitochondrial damage and cell death. Translational studies of AP identified several potential target
molecules that can be modified to prevent intracellular Ca2+ overload. One of the most promising
drugs, a selective inhibitor of the Orai1 channel that has been shown to inhibit extracellular Ca2+
influx and protect cells from injury, is currently being tested in clinical trials. In this review, we will
summarise the recent advances in the field, with a special focus on the translational aspects of the
basic findings.
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1. Ca2+ Signalling and Acute Pancreatitis
Acute pancreatitis (AP) is an inflammatory disease of the pancreas associated with significant
morbidity and mortality. AP is one of the most frequent causes of hospitalisation among non-malignant
gastrointestinal disorders, whereas the global disease incidence has increased in the past several
decades [1–3]. Although overall disease mortality has decreased in recent years [4], the mortality from
severe forms of AP (comprising about 10% of all cases) remains remarkably high (~28%) [5]. AP is
primarily caused by impacted gallstones or heavy alcohol consumption; however, the incidence
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of iatrogenic AP caused by endoscopic retrograde cholangiopancreatography (ERCP) or drug
administration (such as L-asparaginase) has also increased [5]. Regardless of the different pathogenic
factors that may lead to acute inflammation of the pancreas, all cases are associated with sustained
elevated intracellular Ca2+ levels, which are a hallmark of AP pathogenesis [6]. Intracellular Ca2+
overload can lead to premature trypsinogen activation [7,8], mitochondrial damage and cell necrosis in
pancreatic acinar cells [9]. Our group has reported that sustained elevation of intracellular Ca2+ in
ductal cells impairs fluid and HCO3- secretion [10,11], which are key functions of ductal cells, and also
triggers mitochondrial damage with consequent ATP depletion and cell damage [12]. As detailed
below, toxins induce Ca2+ release from the endoplasmic reticulum (ER) intracellular Ca2+ stores, which
is considered as the initial step in the development of sustained Ca2+ elevation. Inhibition of the
uncaged IP3-induced Ca2+ release by caffeine and other non-xanthine phosphodiesterase inhibitors
leads to the impairment of toxin-induced Ca2+ release and prevents mitochondrial depolarisation
and acinar cell necrosis. It also improves the severity of cerulein, bile acid or fatty acid ethyl ester
(FAEE)-induced experimental AP in mice [13]. Sustained Ca2+ signals can lead to mitochondrial
injury, which can activate both apoptosis and necrosis. In the pathogenesis of AP opening of the
mitochondrial permeability transition pore (MPTP) triggered by sustained elevated Ca2+ levels is an
initiating step in mitochondrial membrane potential (∆Ψm) loss, impaired mitochondrial ATP synthesis
and increased permeability of the inner mitochondrial membrane, resulting in mitochondrial swelling
and necrosis [14,15]. Genetic or pharmacologic inhibition of the MPTP resulted in the improvement of
the AP phenotype and acinar [16] and ductal [17] cell injury both in vitro and in vivo.
1.1. Intracellular Ca2+ in Biliary AP
Bile acids are known to trigger dose-dependent elevations in intracellular Ca2+ concentrations
in isolated pancreatic acinar [18] and ductal cells [19] in vitro, which is due to Ca2+ release from
intracellular stores via the activation of IP3 and ryanodine receptors, sarco-endoplasmic reticulum
Ca2+ pump (SERCA) inhibition [20] and extracellular Ca2+ influx activation [21] (Figure 1). The toxic
effects of bile acids on pancreatic acinar cells also involve the activation of the G-protein-coupled cell
surface bile acid receptor (Gpbar1) at the apical membrane, which also contributes to the development
of sustained Ca2+ elevation and its downstream effects [22]. On the other hand, Gpbar1 knockout mice
were protected against taurolithocholic acid 3-sulfate-induced AP, an experimental model of biliary AP.
The pancreatic ductal epithelia can be another possible target of bile acids in the exocrine pancreas.
Previous reports have suggested that increases in intracellular Ca2+ in pancreatic ductal epithelial
cells leads to a marked dose-dependent decrease in HCO3- secretion upon bile acid exposure of
isolated pancreatic ductal fragments [19]. In addition, bile acids inhibit intracellular ATP production
and decreased ∆Ψm in acinar [23,24] and ductal cells [12]. Interestingly, bile acid toxicity was not
abolished by the removal of intracellular Ca2+ elevation using a Ca2+ chelator, BAPTA-AM, neither
in acinar [23] nor in ductal cells [19], suggesting the existence of other parallel Ca2+-independent
effects of bile acids on the mitochondria. Besides inducing mitochondrial toxicity, bile acids have
also been shown to activate calcineurin in a Ca2+-dependent manner in pancreatic cells, leading to
premature digestive enzyme and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)
activation [25]. The inhibition of calcineurin pharmacologically or by genetic knockout, reduced the
severity of taurolithocholate 3-sulfate (TLCS)-induced AP and impaired protein kinase C, an upstream
regulator of NF-κB activation and translocation [26].
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Figure 1. Intracellular Ca2+ signalling in biliary acute pancreatitis. Bile acids dose-dependently release 
Ca2+ from intracellular stores via activation of IP3 and ryanodine receptors (RyR). The inhibition of the 
sarco-endoplasmic reticulum Ca2+ pump (SERCA) and activation of Orai1-mediated extracellular Ca2+ 
influx contributes to the sustained global Ca2+ signals. Bile acids can activate the G-protein-coupled 
cell surface bile acid receptor (Gpbar) at the apical membrane of pancreatic acinar cells that also 
release Ca2+ from the endoplasmic reticulum. Mitochondrial Ca2+ overload can lead to mitochondrial 
damage by opening the mitochondrial permeability transition pore and dissipating the mitochondrial 
membrane potential. In addition, bile acids have been demonstrated to activate calcineurin in a Ca2+-
dependent manner in pancreatic cells, leading to premature digestive enzyme and NF-κB activation. 
1.2. Intracellular Ca2+ in Alcoholic AP 
Heavy alcohol consumption is the second most frequent cause of AP [1]. As only a minority of 
alcoholics develop AP, genetic factors seem to play a major role in disease pathogenesis [27]. 
However, direct treatment with ethanol and different non-oxidative ethanol metabolites have a 
damaging effect on acinar and ductal cells. In contrast to other organs, such as the liver, non-oxidative 
ethanol metabolism is the dominant metabolic pathway in the pancreas [28], which is mediated by 
enzymes with FAEE synthase activity [29], which combine ethanol and fatty acids to generate FAEE 
[30]. Early studies suggested that more than 70% of FAEEs are preferentially accumulated in the 
mitochondria in cardiomyocytes, which is the site of fatty acid hydrolysis [31]. Huang et al. 
investigated FAEE hydrolysis in pancreatic acinar cells using a fluorescently tagged palmitoleic acid 
probe that releases fluorescein upon hydrolysis [32]. Their results suggest that FAEEs accumulate in 
mitochondria and that their local breakdown leads to high concentrations of fatty acids. Like bile 
acids, FAEEs have been shown to induce sustained [Ca2+]i elevation and reduced levels of cellular 
ATP, leading to necrosis [9,33,34] (Figure 2). Our group has demonstrated previously that alcohol 
and fatty acids inhibit fluid and HCO3- secretion in the pancreatic ductal epithelia, mainly due to 
impaired expression and function of the cystic fibrosis transmembrane conductance regulator (CFTR) 
[35], which was restored by ATP supplementation [36]. Inhibition of CFTR activity was mediated by 
sustained intracellular Ca2+ elevation, decreased adenosine 3′,5′-cyclic monophosphate (AMP) levels 
Figure 1. Intracellular Ca2+ signalling in biliary acute pancreatitis. Bile acids dose-dependently release
Ca2+ from intracellular stores via activation of IP3 and ryanodine receptors (RyR). The inhibition of the
sarco-endoplasmic reticulum Ca2+ pump (SERCA) and activation of Orai1-mediated extracellular Ca2+
influx contributes to the sustained global Ca2+ signals. Bile acids can activate the G-protein-coupled cell
surface bile acid receptor (Gpbar) at the apical membrane of pancreatic acinar cells that also release Ca2+
from the endoplasmic reticulum. Mitochondrial Ca2+ overload can lead to mitochondrial damage by
opening the mitochondrial permeability transition pore and dissipating the mitochondrial membrane
potential. In addition, bile acids have been demonstrated to activate calcineurin in a Ca2+-dependent
manner in pancreatic cells, leading to premature digestive enzyme and NF-κB activation.
1.2. Intracellular Ca2+ in Alcoholic AP
Heavy alcohol consumption is the second most frequent cause of AP [1]. As only a minority of
alcoholics develop AP, genetic factors seem to play a major role in disease pathogenesis [27]. However,
direct treatment with ethanol and different non-oxidative ethanol metabolites have a damaging effect
on acinar and ductal cells. In contrast to other organs, such as the liver, non-oxidative ethanol
metabolism is the dominant metabolic pathway in the pancreas [28], which is mediated by enzymes
with FAEE synthase activity [29], which combine ethanol and fatty acids to generate FAEE [30]. Early
studies suggested that more than 70% of FAEEs are preferentially accumulated in the mitochondria
in cardiomyocytes, which is the site of fatty acid hydrolysis [31]. Huang et al. investigated FAEE
hydrolysis in pancreatic acinar cells using a fluorescently tagged palmitoleic acid probe that releases
fluorescein upon hydrolysis [32]. Their results suggest that FAEEs accumulate in mitochondria and
that their local breakdown leads to high concentrations of fatty acids. Like bile acids, FAEEs have
been shown to induce sustained [Ca2+]i elevation and reduced levels of cellular ATP, leading to
necrosis [9,33,34] (Figure 2). Our group has demonstrated previously that alcohol and fatty acids inhibit
fluid and HCO3- secretion in the pancreatic ductal epithelia, mainly due to impaired expression and
function of the cystic fibrosis transmembrane conductance regulator (CFTR) [35], which was restored
by ATP supplementation [36]. Inhibition of CFTR activity was ediated by sustained intracellular
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Ca2+ elevation, decreased adenosine 3′,5′-cyclic monophosphate (AMP) levels and impaired ATP
production accompanied by ∆Ψm depolarisation. Ethanol has reduced CFTR expression via accelerated
plasma membrane turnover and impaired CFTR membrane stability. These alterations in the ductal
cells increased the severity of alcohol-induced AP in mice.
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Figure 2. Intracellular Ca2+ signalling in alcoholic acute pancreatitis. In the pancreas, non-oxidative 
ethanol metabolism is the dominant metabolic pathway mediated by enzymes with fatty acid ethyl 
ester (FAEE) synthase activity, which combine ethanol and fatty acids to generate FAEE. In pancreatic 
acinar cells, FAEEs are accumulated in the mitochondria and their local breakdown leads to localised 
high concentrations of fatty acids. Similar to bile acids, FAEEs induce sustained [Ca2+]i elevation and 
drop of cellular ATP leading to necrosis. In addition, alcohol and fatty acids inhibit fluid and HCO3- 
secretion in the pancreatic ductal epithelia, mainly due to the impaired expression and function of the 
cystic fibrosis transmembrane conductance regulator (CFTR). 
1.3. Intracellular Ca2+ in Drug-Induced AP 
AP is a relatively frequent complication of medical treatments, leading to painful inflammation 
and hospitalisation, and may serve as an indication to alter or cease otherwise effective therapy. 
Asparaginase, a long-term medication used to treat acute lymphoblastic leukaemia (ALL) in children, 
is one of the most likely drugs to induce AP. The incidence of asparaginase-induced AP is above 10% 
[37], making it one of the most common causes for halting therapy for ALL [38]. Recently, Peng et al. 
demonstrated that the treatment of isolated pancreatic acinar cell clusters with asparaginase triggers 
similar changes in intracellular Ca2+ signalling as bile acids and ethanol metabolites [39]. They 
showed that asparaginase treatment leads to intracellular Ca2+ release, followed by extracellular Ca2+ 
entry activation. Ca2+ extrusion was also severely impaired, due to decreased intracellular ATP 
production, leading to cell necrosis. The inhibition of protease-activated receptor 2 (PAR2) abolished 
the toxic intracellular Ca2+ signals, suggesting that the toxic effect of asparaginase is mediated by 
PAR2 activation. In addition, inhibition of the Ca2+ entry by the selective Orai1 inhibitor, GSK-7975A, 
protected acinar cells from Ca2+-induced damage. Similar effects were observed in vitro and in vivo 
Figure 2. Intracellular Ca2+ signalling in alcoholic acute pancreatitis. In the pancreas, no -oxidative
ethanol metabolism is the domina t metabolic pathway mediated by enzymes with fatty acid ethyl
ester (FAEE) synthase activity, which combine ethanol and fatty acids to gen rate FAEE. In pancreatic
acinar cells, FAEEs are accumulated in the mitochondria and their local breakdown leads to l calised
high concentrations of fatty acids. Sim lar to bile acids, FAEEs induce sustained [Ca2+]i elevation and
drop of cellular ATP leading to necrosis. In addition, alcoh l and fatty acids inhibit fluid and HCO3-
secretion i the pancreatic ductal epithelia, mainly due to the impaired expression and function of the
cystic fibrosis transmembrane conductance r gulator (CFTR).
1.3. Intracellular Ca2+ in Drug-Induced AP
AP is a relatively frequent complication of medical treatments, leading to painful inflammation
and hospitalisation, and may serve as an indication to alter or cease otherwise effective therapy.
Asparaginase, a long-term medication used to treat acute lymphoblastic leukaemia (ALL) in children,
is one of the most likely drugs to induce AP. The incidence of asparaginase-induced AP is above
10% [37], making it one of the most common causes for halting therapy for ALL [38]. Recently, Peng
et al. demonstrated that the treatment of isolated pancreatic acinar cell clusters with asparaginase
triggers similar changes in intracellular Ca2+ signalling as bile acids and ethanol metabolites [39].
They showed that asparaginase treatment leads to intracellular Ca2+ release, followed by extracellular
Ca2+ entry activation. Ca2+ extrusion was also severely impaired, due to decreased intracellular ATP
production, leading to cell necrosis. The inhibition of protease-activated receptor 2 (PAR2) abolished
the toxic intracellular Ca2+ signals, suggesting that the toxic effect of asparaginase is mediated by
PAR2 activation. In addition, inhibition of the Ca2+ entry by the selective Orai1 inhibitor, GSK-7975A,
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protected acinar cells from Ca2+-induced damage. Similar effects were observed in vitro and in vivo
by replacing glucose with galactose, which prevented the loss of ATP and protected acinar cells from
necrosis [40].
2. Interplay between Ca2+ and Redox Signalling in Acute Pancreatitis
Reactive oxygen species (ROS) are normal components of physiological signalling processes in
cells. The intracellular level of ROS is balanced by oxidant production and antioxidant processes. ROS
are generated during mitochondrial respiration and are mainly derived from complex I and III of
the mitochondrial electron transport chain [41]. In recent decades, numerous roles of ROS have been
identified to play a variety of roles in intracellular signalling [42]. Booth et al. demonstrated that the
ER–mitochondrial interface hosts a H2O2 nanodomain, which is triggered by increased cytoplasmic
Ca2+ levels and is a positive regulator of Ca2+ oscillations. Such nanodomains can be considered as
important elements in inter-organelle communication [43]. ROS production also exerts various effects
on the ion channels and pumps that are involved in intracellular Ca2+ signalling, which was reviewed
in detail previously [44]. Although ROS play an important role in cellular signalling, unbalanced ROS
production contributes to the pathogenesis of a variety of diseases by disrupting the lipid membranes,
proteins and nucleic acids [45]. In relation to AP, previous studies have shown that ROS generation
determines pancreatic acinar cell fate, as elevated levels of ROS induced by the oxidant menadione led
to increased apoptotic cell death [46]. In addition, bile acids have been shown to induce ROS generation
within the mitochondria in pancreatic acinar cells, leading to mitochondrial Ca2+ increases in both
mice and humans [47], which was inhibited by N-acetylcysteine. Therefore, mitochondrial targeting of
antioxidants may be a potential therapeutic strategy for treating AP. However, mitochondrial targeting
of antioxidants using positively charged molecules that insert into the inner mitochondrial membrane
was harmful to pancreatic acinar cells, most likely due to the wide involvement of ROS in the regulation
of intracellular signalling and bioenergetics [48]. Moreover, during AP pathogenesis, ROS, released by
circulating neutrophils during the inflammatory response, might also contribute to the development of
cell damage and local and systemic complications of AP [49].
Transient Receptor Potential Melastatin-like 2 (TRPM2) is a Ca2+-permeable non-selective cation
channel, which has been identified to act as a cellular redox sensor [50,51], and plays an important
role in physiological processes such as insulin secretion [52] and the central regulation of body
temperature [53]. Perraud et al. demonstrated that TRPM2 is activated by H2O2 via an indirect
mechanism mediated by the intracellular production of adenosine diphosphate ribose (ADPR) which
then binds to and stimulates the C-terminal ADPR pyrophosphatase Nudix-like domain (NUDT9-H
motif) of TRPM2 [54]. This channel not only has prominent roles in physiology, but its contribution
to pathologic conditions was also emphasised [55]. Ca2+ influx mediated by TRPM2 elevates
chemokine production in monocytes, resulting in increased neutrophil infiltration in inflammatory
bowel diseases [56]. In addition, TRPM2 contributes to the pathogenesis of xerostomia induced by
irradiation [57]. Liu et al. demonstrated that ROS production increases as a side effect of irradiation
during radiotherapy of head and neck cancers, leading to TRPM2 activation, resulting in extracellular
Ca2+ influx in salivary glands. Sustained intracellular Ca2+ elevation reduced the secretory function of
acinar cells, leading to the development of xerostomia, which is a common side effect of radiotherapy
in these patients. In addition, after irradiation, mitochondrial Ca2+ concentration and ROS production
are elevated in a TRPM2-dependent manner, leading to impaired ∆ψm and activated caspase-3 [58].
These changes result in a sustained decrease in stromal interaction molecule 1 (Stim1) expression
and decreased store-operated Ca2+ entry (SOCE). In the endocrine pancreas, TRPM2 plays a role in
diabetic stress-induced mitochondrial fragmentation. Abuarab et al. demonstrated that high glucose
concentrations stimulate ROS production, which activates TRPM2, leading to lysosomal membrane
permeabilisation and Zn2+-mediated mitochondrial fission [59]. These studies highlight that TRPM2 is
expressed in various epithelial cells and they demonstrate the fundamental role of this protein in the
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pathogenesis of oxidative-stress-related disease pathogenesis. However, the expression or function of
TRPM2 in exocrine pancreatic cells has not been investigated.
In a recent study, we described the expression of TRPM2 in the exocrine pancreas and established
the role of TRPM2 in biliary AP [60] (Figure 3). TRPM2 was localised to the basolateral membrane
in mouse pancreatic acinar cells, but apically in mouse pancreatic ductal cells. We have found
that H2O2-induced oxidative stress activated TRPM2. In our experiments, CDC resulted in [Ca2+]i
elevation, both in acinar and ductal cells, but the knockout of TRPM2 decreased the CDC-induced
Ca2+ elevation only in acinar cells, suggesting that the TRPM2 channel contributes to approximately
22% of the bile-acid-generated Ca2+ signal in acinar cells. Interestingly, our results demonstrated
that bile-acid-induced intracellular ROS production is remarkably different in pancreatic acinar and
ductal cells. These findings provide a mechanistic explanation for the differing involvement of
TRPM2 in the Ca2+ response generated by bile acid in these different cell types. The difference
in ROS production may be explained by the difference in the mitochondrial mass in acinar versus
ductal cells [12,61]. As expected, we were not able to detect any protective effects due to genetic
deletion of TRPM2 in the inhibition of pancreatic ductal secretion induced by bile acids. In this study,
the lack of TRPM2 significantly reduced the H2O2 and bile-acid-induced necrosis in pancreatic acinar
cells. We also demonstrated that the rate of necrosis was significantly reduced in an experimental
model of biliary pancreatitis in TRPM2 knockout mice as compared to wild type (WT) animals,
consistent with in vitro observations. In agreement with our findings, Booth et al. documented that
incubation of pancreatic acinar cells with TLCS in vitro leads to Ca2+-dependent necrosis, which is
abolished by pre-treatment with BAPTA-AM [47]. Using different inhibitors to prevent apoptosis
and necrosis, the authors suggested that elevated intracellular and intramitochondrial ROS are the
major triggers of apoptosis, while increases in intracellular and intramitochondrial Ca2+ are the
major triggers of necrosis. Bile acids are known to inhibit cellular ATP production [24] and decrease
∆Ψm [23]. Thus, we also measured the effect of bile acid treatment on ∆Ψm in TRPM2 KO and
WT acinar cells. Genetic deletion of TRPM2 or removal of extracellular Ca2+ markedly reduced the
decrease in ∆ψm, suggesting that TRPM2-mediated extracellular Ca2+ influx plays a crucial role in
oxidative-stress-induced mitochondrial damage. In contrast, this protective effect was not detected in
bile-acid-treated cells. This may be explained by the direct Ca2+-independent mitochondrial toxicity
of bile acids [62]. Based on the previous findings of our group [19] and others, [23] we hypothesise
that prevention of intracellular Ca2+ elevation cannot completely abolish the toxic effects of bile acids.
We did not observe mitochondrial fragmentation in our experiments, which has been previously
linked to TRPM2 activation [59]. In addition, genetic deletion of TRPM2 reduced the severity of
bile-acid-induced experimental pancreatitis; however, we did not observe this protective effect in
cerulein-induced AP in TRPM2 knockout mice.
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Figure 3. The role of Transient Potential Melastatin-like 2 (TRPM2) in biliary pancreatitis. Increased, 
unbalanced production of ROS, which are generated during physiological mitochondrial respiration, 
are mainly derived from complexes I and III of the mitochondrial electron transport chain, a crucial 
event in the pathogenesis of biliary acute pancreatitis. In our recent study, we described the 
expression of a redox sensitive cation channel, TRPM2, in the exocrine pancreas with basolateral 
localisation in acinar cells and apical localisation in ductal cells. H2O2-induced oxidative stress 
activated TRPM2, whereas TRPM2 knockout decreased the bile acid-induced Ca2+ elevation in acinar 
cells and prevented acinar cells from bile-acid-induced necrosis. Genetic deletion of TRPM2 reduced 
the severity of bile-acid-induced experimental pancreatitis. 
3. Store-Operated Ca2+ Entry and Acute Pancreatitis 
As highlighted above, sustained intracellular Ca2+ elevation plays a central role in the 
development of cellular injury in AP, regardless of the ethiology. In the polarised pancreatic acinar 
cells, the release of the ER Ca2+ stores in response to physiological agonist stimulation takes place at 
the apical granular region of the cell [63,64] (Figure 4). This apical release is achieved by the invasion 
of ER into the granular pole surrounding zymogen granules [65]. The spatiotemporal localisation and 
thus prevention of the evolution of local IP3-evoked signals to global intracellular Ca2+ elevation is 
prevented by the mitochondria surrounding the apical region of the acinar cells [66], whereas the 
plasma membrane Ca2+ ATPase (PMCA) pumps extrude the Ca2+ at the apical membrane [67]. The 
release of the ER Ca2+ stores activates the influx of extracellular Ca2+, which is mediated by store 
operated Ca2+ entry (SOCE), a process determined by the ER Ca2+ sensor Stim1 [68] and the plasma 
membrane Ca2+ channel Orai1 [69,70]. In unstimulated cells, Stim1 is distributed in the ER membrane, 
whereas the ER Ca2+ store mobilisation induces a conformational change and translocation (puncta 
formation) of Stim1 to the ER–PM junctions [71], leading to the activation of Orai1 and members of 
the TRPC channel family [72–76]. Mogami et al. provided direct functional evidence that Ca2+ entry 
can occur through the basal membrane of the pancreatic acinar cells [77]. In these series of elegant 
experiments, basal Ca2+ entry was controlled with a Ca2+-containing pipette attached to the basal 
membrane in extracellular Ca2+-free media. After recharging the intracellular Ca2+ stores, repeated 
administration of ACh could, again, trigger an increase in intracellular Ca2+ concentration, starting at 
Figure 3. The role of Transient Potential Melastatin-like 2 (TRPM2) in biliary pancreatitis. Increased,
unbal nced production of ROS, which are generated during physiological mitochondrial respiration,
are mainly derived from complexes I and III of the mitochondrial el ctron transport chain, a crucial
event in the pathogenesis of biliary acute pancreatitis. In our recent study, we described the expression
of a redox sensitive cation channel, TRPM2, in the exocrine pancreas with basolateral localisation in
acinar cells and apical localisation in ductal cells. H2O2-induced oxidative stress activated TRPM2,
whereas TRPM2 knockout decreased the bile acid-induced Ca2+ elevation in acinar cells and prevented
acinar cells from bile-acid-induced necrosis. Genetic deletion of TRPM2 reduced the severity of
bile-acid-induced experimental pancreatitis.
3. Store-Operated Ca2+ Entry and Acute Pancreatitis
As highlighted above, sustained intracellular Ca2+ elevation plays a central role in the development
of cellular injury in AP, regardless of the ethiology. In the polarised pancreatic acinar cells, the release
of the ER Ca2+ stores in response to physiological agonist stimulation takes place at the apical granular
region of the cell [63,64] (Figure 4). This apical release is achieved by the invasion of ER into the granular
pole surrounding zymogen granules [65]. The spatiotemporal localisation and thus prevention of
the evolution of local IP3-evoked signals to global intracellular Ca2+ elevation is prevented by the
mitochondria surrounding the apical region of the acinar cells [66], whereas the plasma membrane
Ca2+ ATPase (PMCA) pumps extrude the Ca2+ at the apical membrane [67]. The release of the ER
Ca2+ stores activates the influx of extracellular Ca2+, which is mediated by store operated Ca2+ entry
(SOCE), a process determined by the ER Ca2+ sensor Stim1 [68] and the plasma membrane Ca2+
channel Orai1 [69,70]. In unstimulated cells, Stim1 is distributed in the ER membrane, whereas the
ER Ca2+ store mobilisation induces a conformational change and translocation (puncta formation)
of Stim1 to the ER–PM junctions [71], leading to the activation of Orai1 and members of the TRPC
channel family [72–76]. Mogami et al. provided direct functional evidence that Ca2+ entry can occur
through the basal membrane of the pancreatic acinar cells [77]. In these series of elegant experiments,
basal Ca2+ entry was controlled with a Ca2+-containing pipette attached to the basal membrane in
extracellular Ca2+-free media. After recharging the intracellular Ca2+ stores, repeated administration of
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ACh could, again, trigger an increase in intracellular Ca2+ concentration, starting at the apical secretory
pole. These results suggest that the recharging of the apical ER Ca2+ stores depends on Ca2+ influx
through the basal membrane. However, the cytosolic diffusion of Ca2+ from the basolateral to the
apical pole could have potential unwanted effects. Therefore, the concept of Ca2+ tunneling through
the lumen of the ER has been developed, which suggests that Ca2+ can diffuse more easily within the
ER lumen compared to the cytosol [78,79]. In isolated pancreatic acinar cells, Orai1 expression has been
described independently by two different groups. Lur et al. demonstrated that stimulation-induced
Stim1 translocation occurs in the lateral and basal plasma membranes of acinar cells by utilising
ribosome-free terminals of the ER, which form junctions between the ER and the plasma membrane [80].
Interestingly, and somewhat contradictorily, another study by Hong et al. showed that Orai1 expression
is more pronounced in the apical membrane [81]. The authors also highlighted that agonist stimulation
induced polarised recruitment of Stim1 to the apical and lateral regions, showing approximately 40%
colocalisation with Orai1. The authors found that both Orai1 and TRPC channels contributed to the
frequency of Ca2+ oscillations in acinar cells.
As highlighted, the release of the ER Ca2+ stores activates the influx of extracellular Ca2+, which,
under physiological conditions, helps to maintain secretory responses. However, the presence of
different toxins, which damage mitochondria, lead to the impairment of ATP-dependent Ca2+ extrusion
by PMCA as well as Ca2+ reuptake by SERCA [21]. As a result, the spatiotemporal localisation
of the Ca2+ signal is lost and a global sustained Ca2+ elevation is developed. The pathological
role of Orai1 in pancreatic acinar cells has been highlighted by Gerasimenko et al., who showed
that the inhibition of SOCE via Orai1 decreases acinar cell necrosis in vitro [82]. The authors used
GSK-7975A, a Ca2+ release-activated Ca2+ (CRAC) channel blocker developed by GlaxoSmithKline,
which inhibits SOCE in a concentration-dependent manner and reduces the sustained Ca2+ elevation,
trypsin activation, and acinar necrosis induced by FAEE. Moreover, the inhibition of Orai1 by selective
inhibitors, GSK-7975A and CM-128 by CalciMedica, markedly impaired the extracellular Ca2+ influx
and sustained Ca2+ overload in pancreatic acinar cells upon bile acid stimulation, significantly reducing
pancreatic edema, inflammation and necrosis in experimental models of AP [83]. Using CM4620,
another selective Orai1 channel blocker by CalciMedica, Waldron et al. demonstrated that the
inhibition of SOCE prevents trypsinogen activation, acinar cell death, NF-κB and nuclear factor of
activated T-cells (NFAT) activation, inflammatory responses in in vitro models, and decreases the
severity of experimental AP in mice [84]. In addition, they also showed that CM4620 abolished
myeloperoxidase activity and inflammatory cytokine expression in pancreas and lung tissues and
prevented the oxidative burst in neutrophils. In cerulein-treated mice, cerulein activates SOCE through
a promotion of the interaction between Stim1 and Orai1. Intracellular Ca2+ elevation, induced by
SOCE-activated NFAT and transcription factor EB, led to the calcineurin-promoting transcription of
chemokine genes and autophagy-associated genes [85]. Orai1 was also identified as a central molecule
in regulation of the gut microbiome and host immune system [86]. Orai1 pancreatic acinar conditional
knockout mice display intestinal bacterial outgrowth and dysbiosis, leading to systemic translocation,
inflammation and remarkably reduced survival, all of which were due to the decreased pancreatic
levels of cathelicidin-related antimicrobial peptide. This was markedly improved by treatment with a
liquid diet and broad-spectrum antibiotics, which rescued weight gain and survival.
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Figure 4. Store-operated Ca2+ entry and acute pancreatitis. In pancreatic acinar cells physiological
agonist stimulation releases Ca2+ from the endoplasmic reticulum (ER) stores at the apical granular
region of the cell. The spatiotemporal localisation of IP3-evoked apical signals is maintained by the
mitochondria surrounding the apical region of the acinar cells, whereas the plasma membrane Ca2+
ATPase (PMCA) pumps extrude the Ca2+ at the apical membrane. The influx of extracellular Ca2+
in non-excitable cells is mediated by a process called store-operated Ca2+ entry (SOCE), which is
determined by the ER Ca2+ sensor stromal interaction molecule 1 (Stim1) and the plasma membrane Ca2+
channel Orai1. In unstimulated cells, Stim1 is distributed in the ER membrane, whereas mobilisation of
the ER Ca2+ stores induces a conformational change and translocation with puncta formation, of Stim1
to the ER–PM junctions, which activates Orai1. The basal Ca2+ uptake can refill the apical Ca2+ stores
by a mechanism called Ca2+ tunnelling. Under pathological conditions, the spatiotemporal regulation
of the Ca2+ signalling fails and extracellular Ca2+ entry is an important contributor to the Ca2+ toxicity.
Recently, an Orai1 channel regulator protein called store-operated calcium entry-associated regulatory
factor (Saraf) was described as a crucial component in pathological Ca2+ signal development. Saraf
knockout mice developed more severe acute pancreatitis (AP) compared to controls accompanied by
increased Ca2+ influx in acinar cells, whereas Saraf overexpression reduced acinar Ca2+ influx and
decreased the severity of AP.
On the other hand, genetic deletion of TRPC3 was found to markedly reduce receptor-stimulated
SOCE by about 50% and prevent sustained Ca2+ elevation triggered by the bile acids and ethanol
metabolites. TRPC3 deletion also prevented intracellular trypsin activation and inhibition of digestive
enzyme secretion. These beneficial effects led to reduced severity of cerulein-induced AP in vivo [87].
The same protection was achieved by Pyr3, a TRPC3-specific inhibitor [88].
Although Orai1 inhibition seems to be beneficial in AP, this channel is also necessary for T cell
activation [89]. Therefore, the identification of other potential target proteins is desirable. Recently,
an Orai1 channel regulator protein, called store-operated calcium entry-associated regulatory factor
(Saraf) [90], was described as a crucial component in pathological Ca2+ signal development [91].
In contrast to Stim1 and Orai1 expression, which were not changed during AP, Saraf expression was
decreased during AP in mice and humans. In addition, Saraf knockout mice developed more severe
AP compared to controls, which was accompanied by increased Ca2+ influx in acinar cells. Saraf
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overexpression reduced acinar Ca2+ influx and decreased the severity of AP. These results highlight
the crucial role of Saraf in AP pathogenesis and identify this regulatory protein as potential target
for therapy.
4. Ca2+ Signalling in Pressure-Related Acute Pancreatitis
For several decades, there has been a theory that increased intrapancreatic pressure can lead to
pancreatic damage. Post-ERCP pancreatitis is one of the most common forms of iatrogenic AP, with
a 10% overall incidence and a 0.7% mortality rate [92]. Post-ERCP AP is thought to be provoked
by increased intrapancreatic pressure and intraductal hypertension, in combination with the acidic
radiocontrast solution. Using American opossum as an experimental model of pressure-induced
pancreatitis, Lerch et al. provided evidence that pancreatic outflow obstruction itself, without the
presence of bile acids, is sufficient to trigger necrotising AP [93,94]. Within 6 h of pancreatic and bile
duct ligation, the animals developed transient pancreatic edema and progressive hyperamylasaemia,
followed by acinar cell necrosis, haemorrhage, fat necrosis and inflammatory cell infiltration, within
12 h of duct obstruction. Notably, in other species, duct ligation alone induces only mild pancreatitis,
rather than severe necrotising AP, except in the American opossum [95]. Studies including human
patients have also confirmed that transient obstruction of the pancreatic duct can lead to AP [96,97].
These observations, and the fact that secretory pressure in the pancreatic duct is generally much higher
than in the bile duct [98,99], also lead to the criticism of the common channel formation hypothesis
and bile acid reflux during biliary pancreatitis [100]. More recently, Jin et al. demonstrated that
intracellular Ca2+ signalling plays a central role in the pathogenesis of pressure-related pancreatic
injury. They showed that incubation of mouse and human acinar cells with radiocontrast solutions
triggered sustained intracellular Ca2+ elevation and activated the transcription factors NF-κB and NFAT
via calcineurin. Genetic or pharmacologic inhibition of calcineurin prevented radiocontrast-induced
pancreatic inflammation in mice. In addition, Wen et al. demonstrated that artificially increased
intraductal pressures (100–150 mmHg for 10 min) are sufficient to trigger AP accompanied by
increased serum amylase, cytokine release and tight junction integrity loss [101]. Similar to the
previous observations, pancreatic acinar cells exhibited aberrant intracellular Ca2+ signalling, impaired
mitochondrial function and calcineurin downstream activation (Figure 5). More mechanistic insight
was provided into the development of pressure-induced pancreatic damage by Romac et al. [102].
The authors demonstrated that Piezo1, a mechanoreceptor directly gated by mechanical forces [103],
is expressed in pancreatic acinar cells; application of pressure within the gland leads to AP through
Piezo1 activation. Yoda1 administration, a Piezo1 agonist, triggered intracellular Ca2+ elevation
and acinar cell injury, including mitochondrial depolarisation, trypsinogen activation and acinar cell
necrosis, which was abolished by specific inhibition or genetic dysruption of Piezo1. In addition,
genetic deletion of Piezo1 remarkably decreased the severity of pressure-induced AP, whereas Piezo1
activation by Yoda1 triggered AP without the application of pressure. In another study by the same
group, they showed that mechanical pushing and fluid shear stress increase the intracellular Ca2+ levels
in pancreatic acini [104]. They also provided evidence that Yoda1 administration induces phospholipase
A2 activation, which activates TRPV4. They concluded that TRPV4 activation is necessary for the
development of sustained toxic Ca2+ signals in acinar cells upon pressure.
Although intrapancreatic pressure elevation also affects pancreatic ductal function, none of these
studies assessed ductal secretion [105]. Alkaline secretion of the ductal cells washes out digestive
proenzymes into the duodenum and the alkaline fluid neutralises the protons co-released during
digestive enzyme secretion by pancreatic acinar cells [106]. Increased intraluminal pressure in the
pancreatic ducts was shown to inhibit pancreatic secretion in vitro and in vivo via a serotonin-mediated
pathway, which involves the activation of 5-HT3 receptors in the duct cells [107]. In addition,
the pancreatic fluid and HCO3- secretion is significantly elevated in the absence of peripheral
serotonin [108]. The alkaline intraductal pH also prevents premature trypsinogen activation, as the
autoactivation of trypsinogen is a pH-dependent process, which is accelerated at acidic pH ranges.
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Impaired ductal secretion in CFTR knockout mice alters the membrane dynamics and endocytosis at
the apical plasma membrane of pancreatic acinar cells [109]. Decreased ductal secretion was described
in Na+/H+ exchanger regulatory factor-1 knockout mice due to the loss of CFTR, leading to more severe
experimental AP [110]. Importantly, pharmacological restoration of CFTR function in pancreatic ducts
corrected acinar cell function and decreased pancreatic inflammation [111]. Therefore, maintaining
physiological ductal function and the alkaline luminal pH undoubtedly protects the pancreas from
autodigestion [112]. Based on these findings, we hypothesise that the ductal cells play a significant
part in the development of pressure-related pancreatic injuries, which will need to be further examined
in future studies.
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5. Translational Perspectives
Inflammatory disorders of the pancreas, such as acute and chronic pancreatitis, pose a significant
clinical challenge, as there are currently no specific pharmaceutical treatments available. As discussed
in detail above, basic science studies can identify pathogenic disease mechanisms and novel drug
targets, which can support drug discovery and therapy development in pancreatic diseases. Disturbed
intracellular Ca2+ signalling is a well-established hallmark of the disease, which induces increased
ROS production, mitochondrial damage, intra-acinar digestive enzyme activation, and cell death.
Due to this mechanism of action, preventing toxic cellular Ca2+ overload is currently one of the most
promising therapeutic targets [113]. SOCE inhibition via Orai1 channels improved several key markers
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of AP in vitro and in vivo, as discussed above. Therefore, small-molecule inhibitors of Orai1 channel
seem to be one of the most promising drug candidates to treat AP and its complications. CalciMedica
has successfully completed a Phase I clinical trial enrolling seven patients with AP to assess the
pharmacokinetic and pharmacodynamics profiles of the CM4620 Orai1 channel inhibitor [114]. As a
next step, the company is currently running a Phase II trial (an open-label, dose-response study)
to evaluate the safety and efficacy of CM4620-IE in patients with AP and accompanying systemic
inflammatory response syndrome (SIRS) [115].
Our recent study identified TRPM2 as an important contributor to oxidative-stress-induced cellular
Ca2+ overload in biliary AP. TRPM2 activation contributed to bile-acid-induced extracellular Ca2+
influx in acinar cells, which promoted necrosis in vitro and in vivo. In an experimental model of biliary
AP, genetic knockout of TRPM2 significantly decreased the disease severity and protected acinar cells.
Based on these results, TRPM2 inhibition may be a potential treatment option for biliary pancreatitis
and development of novel TRPM2 inhibitors can be translated to patients. In a recent study, Fourgeaud
et al. identified JNJ-28583113 as a potent selective inhibitor of TRPM2 [116]. They demonstrated that
JNJ-28583113 caused phosphorylation of GSK3α and β subunits of TRPM2 in nM concentrations, which
protected cells from oxidative stress-induced cell injury and impaired cytokine release in response to
pro-inflammatory stimuli in microglia. Although JNJ-28583113 was promising in in vitro experiments,
in vivo administration is currently limited by the rapid metabolisation of the drug. TRPM2 has been
identified as a promising drug target in diseases of the central nervous system, such as neuropathic pain,
bipolar disorder and Alzheimer’s disease, and more potential inhibitors are expected to be identified.
Toxin-induced mitochondrial injury is another key pathogenic step of AP development; therefore,
protection of mitochondrial ATP production is another potential target [117]. Maintenance of ATP
production could provide the necessary ATP to fuel ATP-dependent Ca2+ extrusion mechanisms, such
as SERCA and PMCA pumps, which ensures the spatiotemporal regulation of Ca2+ signals. Opening
of the MPTP, which is a non-specific channel that forms in the inner mitochondrial membrane allowing
passage of particles under 1500 Da, causes loss of the ∆Ψm that is essential to ATP production [118].
MPTP inhibition in pancreatic acinar cells successfully improved the outcome of AP in mice models [16].
Our group also demonstrated that a novel mitochondrial transition pore inhibitor, N-methyl-4-isoleucine
cyclosporin (NIM811), decreases the severity of AP [17]. We demonstrated that NIM811 administration,
an MPTP blocker that acts on cyclophilin D, protects acinar and ductal cells from bile acid and fatty
acid exposure in vitro. NIM811 decreases the severity of AP in vivo in cerulein, bile acid and fatty
acid-induced AP models, making NIM811 a promising candidate for further development.
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